Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Plos One|October 21, 2016
Type 2 Diabetic Mellitus Is a Risk Factor for Nasopharyngeal Carcinoma: A 1:2 Matched Case-Control StudyXing-Si Peng, Guo-Feng Xie, Wen-Ze Qiu, et al.Journal of Cancer|January 4, 2021
Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinomaHao-Yun Tao, Ze-Jiang Zhan, Wen-Ze Qiu, et al.Langmuir : the ACS Journal of Surfaces and Colloids|February 19, 2019
Surface Deposition of Juglone/FeIII on Microporous Membranes for Oil/Water Separation and Dye AdsorptionHui Yu, Qi-Zhi Zhong, Tian-Geng Liu, et al.Oral Oncology|June 18, 2017
A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinomaLiang-Ru Ke, Wei-Xiong Xia, Wen-Ze Qiu, et al.Journal of Cancer|October 30, 2020
Clinical value of nedaplatin-based chemotherapy combined with radiotherapy for locoregional advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysisZe-Jiang Zhan, Hao-Yun Tao, Wen-Ze Qiu, et al.Frontiers in Immunology|August 20, 2021
The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-AnalysisZe-Jiang Zhan, Wen-Yu Yao, Fang Zhang, et al.Angewandte Chemie (International Ed. in English)|October 15, 2020
Engineered Coatings via the Assembly of Amino-Quinone NetworksQi-Zhi Zhong, Joseph J Richardson, Ai He, et al.BMC Cancer|February 17, 2017
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trialLiang-Ru Ke, Wei-Xiong Xia, Wen-Ze Qiu, et al.Plos One|August 11, 2017
A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapyWen-Ze Qiu, Liang-Ru Ke, Wei-Xiong Xia, et al.Oral Oncology|March 30, 2017
Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysisWei-Xiong Xia, Hu Liang, Xing Lv, et al.Pageof 4